CD19 and common variable immunodeficiency: In the case of patients with CLL, we also noted a significant increase in the percentage of CD19+ B cells compared to the other groups of patients and, in patients with CVID, an additional increase in the percentage of CD8+CD3+ T cells (Table 2).